About Eligen B12™
Eligen B12™ is the first and only once-daily oral prescription medical food shown to normalize B12 levels without the need for an injection. Eligen B12™ is indicated for the dietary management of patients who have a medically-diagnosed vitamin B12 deficiency, associated with a disease or condition that cannot be managed by a modification of the normal diet alone. Eligen B12™ is the first product to market using Emisphere’s advanced Eligen® Technology, which utilizes a carrier, salcaprozate sodium or SNAC, to chaperone B12 through the gastric lining and directly into the bloodstream independent of intrinsic factor, a protein made in the stomach that normally facilitates B12 absorption. This groundbreaking technology may have potential application across a broad range of diseases and conditions. Most notably, Eligen® Technology is being used to develop oral formulations of insulin and GLP-1 receptor agonists. Learn more about Eligen B12™ at www.EligenB12.com.
For more information on licensing Eligen B12™ as either a prescription medical food, an OTC medical food or an OTC nutritional supplement please click here.